The News-Gazette, a publication serving Illinois, reports on Prenosis securing a deal for its AI-driven sepsis diagnostic tool, the Sepis ImmunoScore™: CHICAGO — A biotech company with local roots has landed a distribution deal for its AI tool for sepsis diagnosis,...
Prenosis CEO: This AI tool lets doctors better understand your unique biology for sepsis detection–Fox Business
Fox Business, a premier outlet for business and technology insights, featured Prenosis Co-founder & CEO Bobby Reddy, Jr. on The Claman Countdown to discuss how artificial intelligence is transforming healthcare, particularly in the fight against sepsis....
Prenosis nabs de novo nod for AI-powered sepsis risk tool–Fierce Biotech
Fierce Biotech, a trusted source for biotech and healthcare industry news, highlights Prenosis’ groundbreaking FDA authorization for the Sepsis ImmunoScore™, the first De Novo pathway AI tool to transform sepsis diagnosis and prediction: The diagnostics startup...
In a first, FDA authorizes AI-driven test to predict sepsis in hospitals–Washington Post
The Washington Post, a Pulitzer Prize-winning publication with a global readership of millions, featured Prenosis in a detailed profile exploring its groundbreaking FDA-authorized AI diagnostic tool for sepsis. CEO Bobby Reddy, Jr. shares how the Sepsis ImmunoScore™...
FDA authorizes Prenosis software as first AI tool that can diagnose sepsis–CNBC
CNBC, a leading global business and technology news outlet, profiled Prenosis and its groundbreaking Sepsis ImmunoScore™, the first FDA-authorized AI-powered diagnostic tool for sepsis. The story highlights how this innovative solution leverages can transform sepsis...
An AI Tool to Stop Sepsis–Politico
Politico, a leading publication known for its in-depth reporting on policy and innovation, profiled Prenosis: Many algorithms claim to predict sepsis, an extreme immune response to infection that can sometimes be fatal. Prenosis, a Chicago-based health tech company,...
FDA Approves AI Tool That Can Detect Sepsis–Forbes
Forbes, a global leader in business and innovation coverage, profiled Prenosis and its groundbreaking FDA-authorized Sepsis ImmunoScore™: The U.S. Food and Drug Administration approved an AI tool that can diagnose sepsis, Prenosis, the company behind the software,...
FDA clears 1st AI sepsis diagnostic tool–Becker’s
Becker’s Healthcare, a trusted source for clinical and industry news, featured Prenosis and its Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis: The FDA has authorized the nation’s first AI-powered sepsis detection tool, artificial...
FDA OKs first AI tool for sepsis prediction–Axios
Axios, a widely respected outlet known for its national reach and authoritative reporting on health and technology, profiled Prenosis and its FDA-authorized Sepsis ImmunoScore™, the groundbreaking AI-powered tool revolutionizing sepsis prediction and diagnosis with...
Prenosis Among Finalists Named for the 2022 Hearst Health Prize in Partnership With the UCLA Center for SMART Health
LOS ANGELES and SAN FRANCISCO, October 27, 2022 – The UCLA Center for SMART Health, an interdisciplinary collaborative that looks to the integrated transformation of healthcare through emergent data and technologies, and Hearst Health, a division of Hearst and leader...